UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

COVID-19 R0: Magic Number or Conundrum?

Infectious disease reports, 2020-02, Vol.12 (1), p.8516

2020

Volltextzugriff (PDF)

Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity-Response to "Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19"

Critical care (London, England), 2021-12, Vol.25 (1), p.418-418, Article 418

2021

Volltextzugriff (PDF)

Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab

Virology journal, 2023-12, Vol.20 (1), p.301-301, Article 301

2023

Volltextzugriff (PDF)

Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019

American journal of perinatology, 2024-05, Vol.41 (S 01), p.e612

2024

Volltextzugriff (PDF)

Salvage Therapy with Rezafungin for Candida parapsilosis Spondylodiscitis: A Case Report from Expanded Access Program

Microorganisms (Basel), 2024-05, Vol.12 (5), p.903

2024

Volltextzugriff (PDF)

Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma

Frontiers in oncology, 2021-07, Vol.11, p.705948

2021

Volltextzugriff (PDF)

Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience

Heliyon, 2023-02, Vol.9 (2), p.e13126, Article e13126

2023

Volltextzugriff (PDF)

Home Parenteral Nutrition in Patients with Intestinal Failure: Possible Undetected Complications

Nutrients, 2019-03, Vol.11 (3), p.581

2019

Volltextzugriff (PDF)

SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience

Frontiers in medicine, 2022-03, Vol.9, p.864865-864865

2022

Volltextzugriff (PDF)

Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn’s disease

IDCases, 2019-01, Vol.17, p.e00537, Article e00537

2019

Volltextzugriff (PDF)

Microbiota and hepatitis C virus in the era of direct-acting antiviral agents

Microbial pathogenesis, 2023-02, Vol.175, p.105968-105968, Article 105968

2023

Volltextzugriff (PDF)

Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series

Journal of the neurological sciences, 2022-08, Vol.439, p.120306-120306, Article 120306

2022

Volltextzugriff (PDF)

Chest CT in COVID-19 patients: Structured vs conventional reporting

European journal of radiology, 2021-05, Vol.138, p.109621-109621, Article 109621

2021

Volltextzugriff (PDF)

Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies

Expert opinion on drug safety, 2021-10, Vol.20 (10), p.1237-1246

2021

Volltextzugriff (PDF)

Outpatient Use of Monoclonal Antibodies Casirivimab and Imdevimab in Pregnancy for Mild-to-Moderate Coronavirus Disease 2019

American journal of perinatology, 2024-02, Vol.41 (3), p.365

2024

Volltextzugriff (PDF)

Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)

Hepatology international, 2019-01, Vol.13 (1), p.66-74

2019

Volltextzugriff (PDF)

Salvage Therapy with Rezafungin for ICandida parapsilosis/I Spondylodiscitis: A Case Report from Expanded Access Program

Microorganisms (Basel), 2024-05, Vol.12 (5)

2024

Volltextzugriff (PDF)

Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19

Infectious diseases (London, England), 2021-05, Vol.53 (5), p.382-385

2021

Volltextzugriff (PDF)

Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort)

Medicine (Baltimore), 2020-02, Vol.99 (6), p.e18948-e18948

2020

Volltextzugriff (PDF)

Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study

The New microbiologica, 2023-05, Vol.46 (2), p.196-201

2023

Volltextzugriff (PDF)

COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy)

International journal of environmental research and public health, 2022-08, Vol.19 (16), p.10262

2022

Volltextzugriff (PDF)

Epidemiology and pathogenesis of fulminant viral hepatitis in pregnant women

Minerva ginecologica, 2018-08, Vol.70 (4), p.480

2018

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Aktive Filter

ThemaRisk Factors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(41)
Berichte
(5)

Sprache

Englisch
(46)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(31)
Humans
(16)
Covid-19
(13)
Sars-Cov-2
(11)
Patients
(9)
Female
(8)
Infections
(6)
Infectious Diseases
(6)
Cardiac & Cardiovascular Systems
(5)
Cardiovascular System & Cardiology
(5)
Coronaviruses
(5)
Male
(5)
Medicine
(5)
Monoclonal Antibodies
(5)
Severe Acute Respiratory Syndrome Coronavirus 2
(5)
Aged
(4)
Antiviral Agents - Therapeutic Use
(4)
Hcv
(4)
Hospitalization
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

COVID-19 R0: Magic Number or Conundrum?

Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity-Response to "Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19"

Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab

COVID-19 in patients with thymic epithelial tumors with or without Good’s syndrome: a single-center retrospective study

Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019

Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study

Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study

Salvage Therapy with Rezafungin for Candida parapsilosis Spondylodiscitis: A Case Report from Expanded Access Program

Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma

Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience

Home Parenteral Nutrition in Patients with Intestinal Failure: Possible Undetected Complications

SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience

Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn’s disease

Microbiota and hepatitis C virus in the era of direct-acting antiviral agents

Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series

Chest CT in COVID-19 patients: Structured vs conventional reporting

Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies

Outpatient Use of Monoclonal Antibodies Casirivimab and Imdevimab in Pregnancy for Mild-to-Moderate Coronavirus Disease 2019

Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)

Salvage Therapy with Rezafungin for ICandida parapsilosis/I Spondylodiscitis: A Case Report from Expanded Access Program

Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19

Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort)

Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study

COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy)

Epidemiology and pathogenesis of fulminant viral hepatitis in pregnant women

Aktive Filter

Suchergebnisse filtern